Source: Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA CLÍNICA, PLACENTA, ANTIDEPRESSIVOS, GESTANTES
ABNT
CARVALHO, Daniela Miarelli et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, v. 105, n. 4, p. 1003-1008, 2019Tradução . . Disponível em: https://doi.org/10.1002/cpt.1263. Acesso em: 02 out. 2024.APA
Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263NLM
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 out. 02 ] Available from: https://doi.org/10.1002/cpt.1263Vancouver
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 out. 02 ] Available from: https://doi.org/10.1002/cpt.1263